Regulation of immune responses by L-arginine metabolism

Nature Reviews Immunology

Volumn 5, Issue 8, 2005, Pages 641-654

  Bronte, Vincenzo ^a   Zanovello, Paola ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; ARGINASE; ARGININE; CANCER VACCINE; CD11B ANTIGEN; CD18 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CYTOKINE; HYDROGEN PEROXIDE; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RETINOL; TRANSCRIPTION FACTOR; TRYPTOPHAN;

AMINO ACID METABOLISM; BONE MARROW CELL; BONE MARROW DEPRESSION; CELL PROLIFERATION; CLINICAL TRIAL; DRUG ACTIVITY; DRUG MECHANISM; ENZYME INHIBITION; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFECTION; NEOPLASM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SUPPRESSOR CELL; T LYMPHOCYTE; TUMOR GROWTH;

ANIMALS; ARGINASE; ARGININE; HUMANS; IMMUNITY, CELLULAR; MYELOID CELLS; NITRIC OXIDE SYNTHASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SUPPRESSOR FACTORS, IMMUNOLOGIC; T-LYMPHOCYTES;

EID: 23444456772     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1668     Document Type: Review

References (144)

1. Kapsenberg, M. L. Dendritic-cell control of pathogen-driven T-cell polarization. Nature Rev. Immunol. 3, 984-993 (2003).
2. Barreda, D. R., Hanington, P. C. & Belosevic, M. Regulation of myeloid development and function by colony stimulating factors. Dev. Comp. Immunol. 28, 509-554 (2004).
3. Gordon, S. Alternative activation of macrophages. Nature Rev. Immunol. 3, 23-35 (2003).
4. Geissmann, F., Jung, S. & Littman, D. R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71-82 (2003).
5. Kusmartsev, S. & Gabrilovich, D. I. Immature myeloid cells and cancer-associated immune suppression. Cancer Immunol. Immunother. 51, 293-298 (2002).
6. Serafini, P. et al. Derangement of immune responses by myeloid suppressor cells. Cancer Immunol. Immunother. 53, 64-72 (2003).
7. Bronte, V., Serafini, P., Apolloni, E. & Zanovello, P. Tumor-induced immune dysfunctions caused by myeloid suppressor cells. J. Immunother. 24, 431-446 (2001).
8. Baniyash, M. TCR ζ-chain downregulation: curtailing an excessive inflammatory immune response. Nature Rev. Immunol. 4, 675-687 (2004).
9. Gabrilovich, D. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nature Rev. Immunol. 4, 941-952 (2004).
10. Strober, S. Natural suppressor (NS) cells, neonatal tolerance, and total lymphoid irradiation: exploring obscure relationships. Annu. Rev. Immunol. 2, 219-237 (1984). This Review article reports early experimental data on the phenotypic and functional characteristics of NS cells and on the role of NS cells in the alloreactive immune response. It also predicts the involvement of these cells in the development of host-versus-graft and graft-versus-host tolerance in allogeneic bone-marrow chimeras.
11. Holda, J. H., Maier, T & Claman, H. N. Murine graft-versus-host disease across minor barriers: immunosuppressive aspects of natural suppressor cells. Immunol. Rev. 88, 87-105 (1985).
12. + T cells. Blood 96, 3838-3846 (2000).
13. + T cell responses by dysregulating antigen-presenting cell maturation. J. Immunol. 162, 5728-5737 (1999).
14. + cells. J. Immunol. 161, 5313-5320 (1998).
15. Fleming, T. J., Fleming, M. L. & Malek, T. R. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J. Immunol. 151, 2399-2408 (1993).
16. Leenen, P. J., de Bruijn, M. R, Voerman, J. S., Campbell, P. A. & van Ewijk, W. Markers of mouse macrophage development detected by monoclonal antibodies. J. Immunol. Methods 174, 5-19 (1994).
17. Melani, C., Chiodoni, C., Forni, G. & Colombo, M. P. Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity. Blood 102, 2138-2145 (2003).
18. H2 cytokines, tumour-associated myeloid cells and peripheral-blood myeloid cells, and downregulation of CD3ζ expression, which results in inhibition of antigen-specific T-cell responses.
19. + cells in the development of antitumor immunity. Cancer Res. 64, 1130-1139 (2004).
20. + T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J. Immunol. 172, 989-999 (2004).
21. Kusmartsev, S. & Gabrilovich, D. I. STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion. J. Immunol. 174, 4880-4891 (2005).
22. Apolloni, E. et al. Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes. J. Immunol. 165, 6723-6730 (2000).
23. Kusmartsev, S. et al. All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination. Cancer Res. 63, 4441-4449 (2003).
24. Young, M. R. & Wright, M. A. Myelopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: γ interferon plus tumor necrosis factor α synergistically reduces immune suppressor and tumor growth-promoting activities of bone marrow cells and diminishes tumor recurrence and metastasis. Cancer Res. 52, 6335-6340 (1992).
25. + cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 6, 409-421 (2004).
26. Hock, H. et al. Intrinsic requirement for zinc finger transcription factor Gfi-1 in neutrophil differentiation. Immunity 18, 109-120 (2003).
27. Elgert, K. D., Alleva, D. G. & Mullins, D. W. Tumor-induced immune dysfunction: the macrophage connection. J. Leukoc. Biol. 64, 275-290 (1998).
28. Vig, M. et al. Inducible nitric oxide synthase in T cells regulates T cell death and immune memory. J. Clin. Invest. 113, 1734-1742 (2004). Results reported in this paper, together with references 94-98, highlight the involvement of reactive free radicals - both ROS and RNOS, as well as their by-products - in the regulation of T-cell death and immunological memory.
29. Bronte, V. et al. Boosting anti-tumor responses of T lymphocytes infiltrating human prostate cancers. J. Exp. Med. 201, 1257-1268 (2005). This is the first study showing that ARG and NOS activities in human prostate-cancer cells restrain the activation of TILs. It also indicates that peroxynitrites are involved as final mediators of the inhibitory pathways.
30. Brys, L. et al. Reactive oxygen species and 12/15-lipoxygenase contribute to the antiproliferative capacity of alternatively activated myeloid cells elicited during helminth infection. J. Immunol. 174, 6095-6104 (2005).
31. Serafini, P. et al. High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells. Cancer Res. 64, 6337-6343 (2004).
32. De Santo, C. et al. Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination. Proc. Natl Acad. Sci. USA 102, 4185-4190 (2005). This study analyses the effect of NO-releasing aspirin in mouse tumour models. The results show that, by interfering with the inhibitory enzymatic activities of myeloid cells, orally administered NO-releasing aspirin normalizes the immune status of tumour-bearing hosts, increases the number and function of tumour-antigen-specific T cells, and increases the preventive and therapeutic effectiveness of the antitumour immunity elicited by immunization with tumour antigens.
33. Luiking, Y. C., Poeze, M., Dejong, C. H., Ramsay, G. & Deutz, N. E. Sepsis: an arginine deficiency state? Crit. Care Med. 32, 2135-2145 (2004).
34. Bernard, A. C. et al. Alterations in arginine metabolic enzymes in trauma. Shock 15, 215-219 (2001).
35. Wu, G. & Morris, S. M. Jr. Arginine metabolism: nitric oxide and beyond. Biochem. J. 336, 1-17 (1998).
36. Bogdan, C. Nitric oxide and the immune response. Nature Immunol. 2, 907-916 (2001). This comprehensive Review article summarizes recent findings about the role of NO in the immune response, indicating that this molecule and its derivatives have a much more pleiotropic role in infection and immunity than was initially thought. It is also suggested that NO is involved in thymic education.
37. Vincendeau, P., Gobert, A. P., Daulouede, S., Moynet, D. & Djavad Mossalayi, M. Arginases in parasitic diseases. Trends Parasitol. 19, 9-12 (2003).
38. Gobert, A. P. et al. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc. Natl Acad. Sci. USA 98, 13844-13849 (2001).
39. ω-hydroxy-L-arginine controls the growth of Leishmania inside macrophages. J. Exp. Med. 193, 777-784 (2001).
40. H2 phenotype. J. Immunol. 160, 5347-5354 (1998).
41. H2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J. Immunol. 163, 3771-3777 (1999).
42. Boutard, V. et al. Transforming growth factor-β stimulates arginase activity in macrophages. Implications for the regulation of macrophage cytotoxicity. J. Immunol. 155, 2077-2084 (1995).
43. Morrison, A. C. & Correll, P. H. Activation of the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase by macrophage-stimulating protein results in the induction of arginase activity in murine peritoneal macrophages. J. Immunol. 168, 853-860 (2002).
44. Jost, M. M. et al. Divergent effects of GM-CSF and TGFβ1 on bone marrow-derived macrophage arginase-1 activity, MCP-1 expression, and matrix metalloproteinase-12: a potential role during arteriogenesis. FASEB J. 17, 2281-2283 (2003).
45. Morris, S. M. Jr. Regulation of enzymes of the urea cycle and arginine metabolism. Annu. Rev. Nutr. 22, 87-105 (2002).
46. Rutschman, R. et al. State-dependent substrate depletion regulates nitric oxide production. J. Immunol. 166, 2173-2177 (2001).
47. Sinha, P., Clements, V. K. & Ostrand-Rosenberg, S. Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease. J. Immunol. 174, 636-645 (2005).
48. Munder, M. et al. Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood 105, 2549-2556 (2005).
49. Kim, J. W., Gloss, E. I., Albritton, L. M. & Cunningham, J. M. Transport of cationic amino acids by the mouse ecotropic retrovirus receptor. Nature 352, 725-728 (1991).
50. Mann, G. E., Yudilevich, D. L. & Sobrevia, L. Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol. Rev. 83, 183-252 (2003).
51. Rodriguez, P. C. et al. L-Arginine consumption by macrophages modulates the expression of CD3 ζ chain in T lymphocytes. J. Immunol. 171, 1232-1239 (2003).
52. Alderton, W. K., Cooper, C. E. & Knowles, R. G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357, 593-615 (2001).
53. Kleinert, H. et al. Cytokine induction of NO synthase II in human DLD-1 cells: roles of the JAK-STAT, AP-1 and NF-κB-signaling pathways. Br. J. Pharmacol. 125, 193-201 (1998).
54. Ganster, R. W., Taylor, B. S., Shao, L. & Geller, D. A. Complex regulation of human inducible nitric oxide synthase gene transcription by Stat1 and NF-κB. Proc. Natl Acad. Sci. USA 98, 8638-8643 (2001).
55. Angulo, I. et al. Early myeloid cells are high producers of nitric oxide upon CD40 plus IFN-γ stimulation through a mechanism dependent on endogenous TNF-α and IL-1α. Eur. J. Immunol. 30, 1263-1271 (2000).
56. + cells in the spleen of cyclophosphamide-treated mice: implications for T-cell responses in immunosuppressed mice. Blood 95, 212-220 (2000).
57. + immature myeloid suppressor cells. Int. Immunol. 14, 1125-1134 (2002).
58. Waddington, S. N., Mosley, K., Cook, H. T., Tam, F. W. & Cattell, V. Arginase Al is upregulated in acute immune complex-induced inflammation. Biochem. Biophys. Res. Commun. 247, 84-87 (1998).
59. Noel, W., Raes, G., Hassanzadeh Ghassabeh, G., De Baetselier, P. & Beschin, A. Alternatively activated macrophages during parasite infections. Trends Parasitol. 20, 126-133 (2004).
60. Bronte, V., Serafini, P., Mazzoni, A., Segal, D. M. & Zanovello, P. L-Arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol. 24, 301-305 (2003).
61. Bronte, V. et al. IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. J. Immunol. 170, 270-278 (2003).
62. Currie, G. A., Gyure, L. & Cifuentes, L. Microenvironmental arginine depletion by macrophages In vivo. Br. J. Cancer 39, 613-620 (1979).
63. Zhang, P. et al. The GCN2 elF2α kinase is required for adaptation to amino acid deprivation in mice. Mol. Cell. Biol. 22, 6681-6688 (2002).
64. Lee, J., Ryu, H., Ferrante, R. J., Morris, S. M. Jr. & Ratan, R. R. Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox. Proc. Natl Acad. Sci. USA 100, 4843-4848 (2003).
65. El-Gayar, S., Thuring-Nahler, H., Pfeilschifter, J., Rollinghoff, M. & Bogdan, C. Translational control of inducible nitric oxide synthase by IL-13 and arginine availability in inflammatory macrophages. J. Immunol. 171, 4561-4568 (2003).
66. Rohde, J., Heitman, J. & Cardenas, M. E. The TOR kinases link nutrient sensing to cell growth. J. Biol. Chem. 276, 9583-9586 (2001).
67. Gao, X. et al. Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nature Cell Biol. 4, 699-704 (2002).
68. Zhang, M. et al. Spermine inhibits proinflammatory cytokine synthesis in human mononuclear cells: a counterregulatory mechanism that restrains the immune response. J. Exp. Med. 185, 1759-1768 (1997).
69. Fischer, T. A. et al. Activation of cGMP-dependent protein kinase Iβ inhibits interleukin 2 release and proliferation of T cell receptor-stimulated human peripheral T cells. J. Biol. Chem. 276, 5967-5974 (2001).
70. Duhe, R. J. et al. Nitric oxide and thiol redox regulation of Janus kinase activity. Proc. Natl Acad. Sci. USA 95, 126-131 (1998).
71. Bingisser, R. M., Tilbrook, P. A., Holt, P. G. & Kees, U. R. Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway. J. Immunol. 160, 5729-5734 (1998).
72. Mazzoni, A. et al. Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. J. Immunol. 168, 689-695 (2002).
73. Macphail, S. E. et al. Nitric oxide regulation of human peripheral blood mononuclear cells: critical time dependence and selectivity for cytokine versus chemokine expression. J. Immunol. 171, 4809-4815 (2003).
74. Pericle, F. et al. HIV-1 infection induces a selective reduction in STAT5 protein expression. J. Immunol. 160, 28-31 (1998).
75. Pericle, F. et al. Immunocompromised tumor-bearing mice show a selective loss of STAT5a/b expression in T and B lymphocytes. J. Immunol. 159, 2580-2585 (1997).
76. Mannick, J. B. et al. Fas-induced caspase denitrosylation. Science 284, 651-654 (1999).
77. Fligger, J., Blum, J. & Jungi, T. W. Induction of intracellular arginase activity does not diminish the capacity of macrophages to produce nitric oxide in vitro. Immunobiology 200, 169-186 (1999).
78. Xia, Y. & Zweier, J. L. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc. Natl Acad. Sci. USA 94, 6954-6958 (1997).
79. Xia, Y., Roman, L. J., Masters, B. S. & Zweier, J. L. Inducible nitric-oxide synthase generates superoxide from the reductase domain. J. Biol. Chem. 273, 22635-22639 (1998).
80. Radi, R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc. Natl Acad. Sci. USA 101, 4003-4008 (2004).
81. Schopfer, F. J., Baker, P. R. & Freeman, B. A. NO-dependent protein nitration: a cell signaling event or an oxidative inflammatory response? Trends Biochem. Sci. 28, 646-654 (2003).
82. Denicola, A., Souza, J. M. & Radi, R. Diffusion of peroxynitrite across erythrocyte membranes. Proc. Natl Acad. Sci. USA 95, 3566-3571 (1998).
83. Brito, C. et al. Peroxynitrite inhibits T lymphocyte activation and proliferation by promoting impairment of tyrosine phosphorylation and peroxynitrite-driven apoptotic death. J. Immunol. 162, 3356-3366 (1999).
84. Aulak, K. S. et al. Proteomic method identifies proteins nitrated in vivo during inflammatory challenge. Proc. Natl Acad. Sci. USA 98, 12056-12061 (2001).
85. Moulian, N., Truffault, F., Gaudry-Talarmain, Y. M., Serraf, A. & Berrih-Aknin, S. In vivo and in vitro apoptosis of human thymocytes are associated with nitrotyrosine formation. Blood 97, 3521-3530 (2001).
86. Reth, M. Hydrogen peroxide as second messenger in lymphocyte activation. Nature Immunol. 3, 1129-1134 (2002).
87. + myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation. J. Immunol. 165, 779-785 (2000).
88. Otsuji, M., Kimura, Y., Aoe, T., Okamoto, Y. & Saito, T. Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 ζ chain of T-cell receptor complex and antigen-specific T-cell responses. Proc. Natl Acad. Sci. USA 93, 13119-13124 (1996).
89. Schmielau, J. & Finn, O. J. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients. Cancer Res. 61, 4756-4760 (2001).
90. Zea, A. H. et al. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 65, 3044-3048 (2005).
91. Hildeman, D. A. et al. Control of Bcl-2 expression by reactive oxygen species. Proc. Natl Acad. Sci. USA 100, 15035-15040 (2003).
92. + T cells after infection. Nature Immunol. 3, 619-626 (2002).
93. + T-cell responses is controlled by inflammation and IFN-γ production in the early stages of infection.
94. + T cells during primary but not secondary viral infection. J. Virol. 78, 11246-11257 (2004).
95. Cauley, L. S., Miller, E. E., Yen, M. & Swain, S. L. Superantigen-induced CD4 T cell tolerance mediated by myeloid cells and IFN-γ. J. Immunol. 165, 6056-6066 (2000).
96. Devadas, S., Zaritskaya, L., Rhee, S. G., Oberley, L. & Williams, M. S. Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and Fas ligand expression. J. Exp. Med. 195, 59-70 (2002).
97. Hildeman, D. A. et al. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10, 735-744 (1999).
98. Hildeman, D. A., Mitchell, T., Kappler, J. & Marrack, P. T cell apoptosis and reactive oxygen species. J. Clin. Invest. 111, 575-581 (2003).
99. Bronstein-Sitton, N. et al. Sustained exposure to bacterial antigen induces interferon-γ-dependent T cell receptor ζ down-regulation and impaired T cell function. Nature Immunol. 4, 957-964 (2003).
100. Xu, W., Liu, L., Smith, G. C. & Charles, G. Nitric oxide upregulates expression of DNA-PKcs to protect cells from DNA-damaging anti-tumour agents. Nature Cell Biol. 2, 339-345 (2000).
101. Cederbaum, S. D. et al. Arginases I and II: do their functions overlap? Mol. Genet. Metab. 81, S38-S44 (2004).
102. Chang, C. I., Liao, J. C. & Kuo, L. Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity. Cancer Res. 61, 1100-1106 (2001).
103. Davel, L. E. et al. Arginine metabolic pathways involved in the modulation of tumor-induced angiogenesis by macrophages. FEBS Lett. 532, 216-220 (2002).
104. Schleifer, K. W. & Mansfield, J. M. Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins. J. Immunol. 151, 5492-5503 (1993).
105. Abrahamsohn, I. A. & Coffman, R. L. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. J. Immunol. 155, 3955-3963 (1995).
106. + cells: a potential mechanism for immune polarization in helminth infections. J. Immunol. 167, 5294-5303 (2001).
107. H1 immunity in mice with candidiasis. J. Immunol. 169, 3180-3190 (2002).
108. Zabaleta, J. et al. Helicobacter pylori arginase inhibits T cell proliferation and reduces the expression of the TCR ζ-chain (CD3ζ). J. Immunol. 173, 586-593 (2004).
109. Pelaez, B., Campillo, J. A., Lopez-Asenjo, J. A. & Subiza, J. L. Cyclophosphamide induces the development of early myeloid cells suppressing tumor cell growth by a nitric oxide-dependent mechanism. J. Immunol. 166, 6608-6615 (2001).
110. + early myeloid cells with suppressor activity in spleens of murine radiation marrow chimeras. Possible implications for the graft-versus-host and graft-versus-leukemia reactivity of donor lymphocyte infusions. Blood 102, 740-748 (2003).
111. Vallance, P. & Leiper, J. Blocking NO synthesis: how, where and why? Nature Rev. Drug Discov. 1, 939-950 (2002).
112. Colleluori, D. M. & Ash, D. E. Classical and slow-binding inhibitors of human type II arginase. Biochemistry 40, 9356-9362 (2001). References 111 and 112 focus on the rationale and potential for approaches that reduce the synthesis of NO and the activity of ARG, and they discuss the application of these approaches in clinical settings.
113. Gupta, S. et al. Chemoprevention of prostate carcinogenesis by α-difluoromethylornithine in TRAMP mice. Cancer Res. 60, 5125-5133 (2000).
114. Wallace, J. L., Ignarro, L. J. & Fiorucci, S. Potential cardioprotective actions of NO-releasing aspirin. Nature Rev. Drug Discov. 1, 375-382 (2002).
115. Mellor, A. L. & Munn, D. H. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nature Rev. Immunol. 4, 762-774 (2004).
116. Fenyk-Melody, J. E. et al. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J. Immunol. 160, 2940-2946 (1998).
117. Shi, F. D. et al. Control of the autoimmune response by type 2 nitric oxide synthase. J. Immunol. 167, 3000-3006 (2001).
118. Grohmann, U. et al. A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice. J. Exp. Med. 198, 153-160 (2003).
119. Fallarino, F. et al. CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice. J. Exp. Med. 200, 1051-1062 (2004).
120. de Jonge, W. J. et al. Arginine deficiency affects early B cell maturation and lymphoid organ development in transgenic mice. J. Clin. Invest. 110, 1539-1548 (2002). This study shows that the impaired transition from pro-B cells to precursor-B cells in the bone marrow of transgenic mice is characterized by high expression of ARG1 in enterocytes, thereby indicating that a signal-transduction molecule associated with L-arginine metabolism might be involved in B-cell maturation.
121. G-hydroxy-L-arginine and nitric oxide inhibit Caco-2 tumor cell proliferation by distinct mechanisms. Am. J. Physiol. Regul. Integr. Comp. Physiol. 275, R1256-R1264 (1998).
122. Blachier, F., Mignon, A. & Soubrane, O. Polyamines inhibit lipopolysaccharide-induced nitric oxide synthase activity in rat liver cytosol. Nitric Oxide 1, 268-272 (1997).
123. Meurs, H., Maarsingh, H. & Zaagsma, J. Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsiveness. Trends Pharmacol. Sci. 24, 450-455 (2003).
124. Gabrilovich, D. et al. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 92, 4150-4166 (1998).
125. Young, M. R., Wright, M. A. & Young, M. E. Antibodies to colony-stimulating factors block Lewis lung carcinoma cell stimulation of immune-suppressive bone marrow cells. Cancer Immunol. Immunother. 33, 146-152 (1991).
126. Passegue, E., Jochum, W., Schorpp-Kistner, M., Mohle-Steinlein, U. & Wagner, E. F. Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking JunB expression in the myeloid lineage. Cell 104, 21-32 (2001).
127. Ghansah, T. et al. Expansion of myeloid suppressor cells in SHIP-deficient mice represses allogeneic T cell responses. J. Immunol. 173, 7324-7330 (2004).
128. Welte, T. et al. STATS deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc. Natl Acad. Sci. USA 100, 1879-1884 (2003).
129. Kuwata, T. et al. Vitamin A deficiency in mice causes a systemic expansion of myeloid cells. Blood 95, 3349-3356 (2000).
130. Munn, D. H. et al. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189, 1363-1372 (1999).
131. Grohmann, U. et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nature Immunol. 3, 1097-1101 (2002).
132. + T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J. Immunol. 172, 4100-4110 (2004).
133. Frumento, G. et al. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J. Exp. Med. 196, 459-468 (2002).
134. H2 paradigm. J. Immunol. 164, 6166-6173 (2000).
135. Chon, S. Y., Hassanain, H. H. & Gupta, S. L. Cooperative role of interferon regulatory factor 1 and p91 (STAT1) response elements in interferon-γ-inducible expression of human indoleamine 2,3-dioxygenase gene. J. Biol. Chem. 271, 17247-17252 (1996).
136. Weiner, C. P., Knowles, R. G., Stegink, L. D., Dawson, J. & Moncada, S. Myometrial arginase activity increases with advancing pregnancy in the guinea pig. Am. J. Obstet. Gynecol. 174, 779-782 (1996).
137. Mellor, A. L. et al. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nature Immunol. 2, 64-68 (2001).
138. Uyttenhove, C. et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nature Med. 9, 1269-1274 (2003).
139. Munn, D. H. et al. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J. Clin. Invest. 114, 280-290 (2004).
140. + T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide. J. Immunol. 167, 5583-5593 (2001).
141. Hongo, D., Bryson, J. S., Kaplan, A. M. & Cohen, D. A. Endogenous nitric oxide protects against T cell-dependent lethality during graft-versus-host disease and idiopathic pneumonia syndrome. J. Immunol. 173, 1744-1756 (2004).
142. Fallarino, F. et al. Modulation of tryptophan catabolism by regulatory T cells. Nature Immunol. 4, 1206-1212 (2003).
143. + cells in a model of allogeneic transplantation, this article shows the proliferation of IL-10-secreting and antigen-specific regulatory T cells that attenuate graft-versus-host disease but not graft-versus-leukaemia effects.
144. Hucke, C., MacKenzie, C. R., Adjogble, K. D., Takikawa, O. & Daubener, W. Nitric oxide-mediated regulation of γ interferon-induced bacteriostasis: inhibition and degradation of human indoleamine 2,3-dioxygenase. Infect. Immun. 72, 2723-2730 (2004).